Response to therapy is independently associated with survival prolongation in chronic myelogenous leukemia in the blastic phase.

Source:http://linkedlifedata.com/resource/pubmed/id/11745182

Cancer 2001 Nov 15 92 10 2501-7

Download in:

View as

General Info

PMID
11745182